- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07350330
Comparative Study of Muscle Transplantation Versus Y Splitting Recession Technique in Treatment of Large Angle Exotropia
January 14, 2026 updated by: Ain Shams University
This study is designed to correct large-angle exotropia by monocular surgery.
It compares two augmented recession techniques, which are recession with muscle transplantation and recession with Y splitting.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Alaa Mohsen Elmaghraby, masters
- Phone Number: +201115538151
- Email: Alaa.Mohsen@med.asu.edu.eg
Study Locations
-
-
-
Cairo, Egypt
- Recruiting
- Ain shams university
-
Contact:
- Alaa Mohsen Elmaghraby, masters
- Phone Number: +201115538151
- Email: Alaa.Mohsen@med.asu.edu.eg
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age should be of more than 6 years Exotropia of an angle ranging from 50 to 70 PD Myopic or hypermetropic refraction
Exclusion Criteria:
- history of previous squint surgery significant vertical deviation incomitant squint in the form of paralytic or restrictive disorder any neurological disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Muscle transplantation
This group will undergo medial rectus resection, lateral rectus recession, with muscle transplantation
|
transplanting a resected part of medial rectus to the already recessed lateral rectus muscle
|
|
Active Comparator: Y splitting
This group will undergo medial rectus resection, lateral rectus recession, with Y splitting
|
Y splitting of the recessed lateral rectus muscle
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ocular alignment
Time Frame: from the operation till six months postoperatively
|
To measure ocular alignment using prisms after lateral rectus recession with muscle transplantation versus lateral rectus recession with Y splitting
|
from the operation till six months postoperatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
palpebral fissure height
Time Frame: from preoperative to 6 months postoperative
|
Assess whether this is a change in palpebral fissure height pre- and postoperatively by measurement using a ruler
|
from preoperative to 6 months postoperative
|
|
ocular incomitance
Time Frame: from surgery till 6 months afterward
|
The presence of ocular incomitance and gaze restriction using prisms and motility tests after surgery
|
from surgery till 6 months afterward
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 30, 2025
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
December 30, 2026
Study Registration Dates
First Submitted
December 20, 2025
First Submitted That Met QC Criteria
January 14, 2026
First Posted (Actual)
January 20, 2026
Study Record Updates
Last Update Posted (Actual)
January 20, 2026
Last Update Submitted That Met QC Criteria
January 14, 2026
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FMASU MD223/2025
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Exotropia
-
Yonsei UniversityCompletedExotropia or Intermittent ExotropiaKorea, Republic of
-
Retina Foundation of the SouthwestRecruiting
-
Nunaps IncCompletedIntermittent ExotropiaSouth Korea
-
Retina Foundation of the SouthwestActive, not recruiting
-
Singapore National Eye CentreTerminatedIntermittent ExotropiaSingapore
-
Indiana University School of MedicineTerminatedIntermittent ExotropiaUnited States
-
Jaeb Center for Health ResearchNational Eye Institute (NEI); Pediatric Eye Disease Investigator GroupCompletedIntermittent ExotropiaUnited States
-
Samsung Medical CenterCompletedIntermittent Exotropia
-
Benha UniversityCompletedIntermittent ExotropiaEgypt
-
Jaeb Center for Health ResearchNational Eye Institute (NEI); Pediatric Eye Disease Investigator GroupCompleted
Clinical Trials on muscle transplantation
-
South Valley UniversityEnrolling by invitation
-
Brigham and Women's HospitalUnited States Department of DefenseCompleted
-
Icahn School of Medicine at Mount SinaiTerminatedAlopecia | Alopecia Areata | BaldingUnited States
-
Azienda Ospedaliera di PadovaUnknownPrimary Sclerosing Cholangitis | Hilar CholangiocarcinomaItaly
-
Assistance Publique - Hôpitaux de ParisPierre and Marie Curie University; ANRS, Emerging Infectious Diseases; Institut...Completed
-
Azienda Ospedaliera San Giovanni BattistaUnknownMultiple MyelomaItaly
-
Sidney Kimmel Cancer Center at Thomas Jefferson...WithdrawnAnemia | Thrombocytopenia | Neutropenia | Hematopoietic/Lymphoid Cancer | Lymphopenia
-
Tampere University HospitalUniversity of HelsinkiCompletedMicrobial Colonization | Fatigue Syndrome, ChronicFinland
-
Wake Forest University Health SciencesNot yet recruiting